RICHARD SCHOLLAERT: Open Payments
NPI 1962428292 · AMBRIDGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,371 in 117 payments from 21 companies in 2025. Trend: 2023 $1,751 · 2024 $1,907 · 2025 $2,371
Food & beverage: $2,371
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $578 |
| AstraZeneca Pharmaceuticals LP | 18 | $405 |
| GlaxoSmithKline, LLC. | 14 | $239 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $158 |
| Amgen Inc. | 7 | $130 |
| Otsuka America Pharmaceutical, Inc. | 5 | $129 |
| Lilly USA, LLC | 6 | $120 |
| E.R. Squibb & Sons, L.L.C. | 5 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| PFIZER INC. | 4 | $81 |
Products named: Ozempic, TRELEGY ELLIPTA, BREZTRI, Wegovy, AIRSUPRA, JARDIANCE, REXULTI, MOUNJARO.
Industry payments across PA — which companies pay providers there.
